Page last updated: 2024-10-18

dimethyl sulfoxide and Carcinoma, Basal Cell, Pigmented

dimethyl sulfoxide has been researched along with Carcinoma, Basal Cell, Pigmented in 9 studies

Dimethyl Sulfoxide: A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation.
dimethyl sulfoxide : A 2-carbon sulfoxide in which the sulfur atom has two methyl substituents.

Research Excerpts

ExcerptRelevanceReference
"Skin cancer is the most common cancer in the United States and among Caucasians worldwide, with more people diagnosed each year than all other cancers combined."3.11Randomized trial of topical ascorbic acid in DMSO versus imiquimod for the treatment of basal cell carcinoma. ( Bailie, JE; Burke, B, 2022)
" CT-3 was devoid of GI ulceration when administered with DMSO either acutely at doses below 100 mg/kg or chronically at a dosage of 30 mg/kg/day for 5 days."1.301',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties. ( Dajani, EZ; Dajani, NE; Dayton, MT; Larsen, KR; Mir, GN; Neeleman, SD; Shahwan, TG; Taylor, J; Taylor, MS, 1999)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19902 (22.22)18.7374
1990's4 (44.44)18.2507
2000's2 (22.22)29.6817
2010's0 (0.00)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Burke, B1
Bailie, JE1
Christensen, E1
Skogvoll, E1
Viset, T1
Warloe, T4
Sundstrøm, S1
Peng, Q1
Moan, J2
Heyerdahl, H1
Steen, HB2
Nesland, JM1
Giercksky, KE2
Harth, Y1
Hirshowitz, B1
Kaplan, B1
Soler, AM2
Tausjø, J2
Berner, A1
Dajani, EZ1
Larsen, KR1
Taylor, J1
Dajani, NE1
Shahwan, TG1
Neeleman, SD1
Taylor, MS1
Dayton, MT1
Mir, GN1
Angell-Petersen, E1
Hollander, A1
Garcia-Perez, A1
Aparicio, M1
Carapeto, FJ1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Dimethylsulphoxide-supported Photodynamic Therapy of Basal Cell Carcinoma Combined With Curettage - A 6 Year Clinical and Histological Evaluation.[NCT00218829]44 participants (Actual)Observational1997-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for dimethyl sulfoxide and Carcinoma, Basal Cell, Pigmented

ArticleYear
[News concerning dermatology in America. II].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1969, Volume: 20, Issue:3

    Topics: Adolescent; Adult; Aged; Anti-Infective Agents, Local; Antifungal Agents; Carcinoma, Basal Cell; Chi

1969

Trials

2 trials available for dimethyl sulfoxide and Carcinoma, Basal Cell, Pigmented

ArticleYear
Randomized trial of topical ascorbic acid in DMSO versus imiquimod for the treatment of basal cell carcinoma.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 148

    Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Ascorbic Acid; Carcinoma, Basal Cel

2022
Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources.
    Photochemistry and photobiology, 2000, Volume: 71, Issue:6

    Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Dimethyl Sulfoxide; Edetic Acid; Female; Humans; Light;

2000

Other Studies

6 other studies available for dimethyl sulfoxide and Carcinoma, Basal Cell, Pigmented

ArticleYear
Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2009, Volume: 23, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Dimethyl Sulfoxide; Fema

2009
Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma.
    Photochemistry and photobiology, 1995, Volume: 62, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Dimethyl Sulfoxide; Huma

1995
Modified topical photodynamic therapy of superficial skin tumors, utilizing aminolevulinic acid, penetration enhancers, red light, and hyperthermia.
    Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 1998, Volume: 24, Issue:7

    Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Bowen's Disease; Carcinoma, Basal Cell; Carcin

1998
Photodynamic therapy by topical aminolevulinic acid, dimethylsulphoxide and curettage in nodular basal cell carcinoma: a one-year follow-up study.
    Acta dermato-venereologica, 1999, Volume: 79, Issue:3

    Topics: Administration, Topical; Aminolevulinic Acid; Anti-Inflammatory Agents; Biopsy; Carcinoma, Basal Cel

1999
1',1'-Dimethylheptyl-delta-8-tetrahydrocannabinol-11-oic acid: a novel, orally effective cannabinoid with analgesic and anti-inflammatory properties.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:1

    Topics: Administration, Oral; Analgesia; Analgesics; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Ag

1999
Comparison of the clinical and histological effects of 5-fluorouracil (5-FU) alone and of 5-FU preceded by dimethyl-sulphoxide (DMSO) on senile keratosis.
    Dermatologica, 1970, Volume: 140

    Topics: Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Dimethyl Sulfoxide; Fluorouracil; Humans; Keratosis

1970